Arterosil

Arterosil

$99.00
  • Promotes a healthy heart*
  • Maintains a healthy artery wall*
  • Arterosil helps maintain blood pressure in the normal range*
    • Promotes a healthy heart*
  • Maintains a healthy artery wall*
  • Arterosil helps maintain blood pressure in the normal range*
  • 100% Guarantee

    Dr. Shippy Approved


    Gluten-free
    Dairy-free
    Soy-free
    Non-GMO

    Arterosil® is the world's first glycocalyx-regenerating supplement. It is also the only product patented to stabilize and regress vulnerable plaque. 

    Your blood vessels have a micro-thin gel lining called the endothelial glycocalyx. The glycocalyx protects and regulates the entire endothelium and is therefore the foundation of vascular health.

    It inhibits cholesterol and other harmful particles from adhering to or penetrating the endothelial wall.

    This critical and delicate structure can be compromised by many common conditions, such as high blood glucose, oxidative stress, inflammation, aging, and several health conditions. 

    Arterosil supports normal endothelial function, promotes a healthy heart, improves blood flow, and helps maintain blood pressure in the normal range.*

    Arterosil also helps support normal erectile function in men.* 

    In addition, Arterosil is the only dietary supplement of any type with a US patent targeting vulnerable plaque. 

    Arterosil contains MonitumRS™ – a proprietary extract of rhamnan sulfate, a specialized sulfated polysaccharide derived from the rare green seaweed, Monostroma nitidum.

    Rhamnan sulfate is a powerful glycocalyx-regenerating compound that has been reported to possess many cardiovascular health benefits.

    Daily use of Arterosil is clinically proven to protect and restore the endothelial glycocalyx. 

    Serving Size: 2 Capsules 

    Servings per Container: 30

     

    References

    1. Bernhard F. Becker, Daniel Chappell, Dirk Bruegger, Thorsten Annecke & Matthias Jacob. Therapeutic Strategies Targeting the Endothelial Glycocalyx: Acute Deficits, but Great Potential. Cardiovascular Research (2010) 87:300–310.

    2. Bernard F. Becker, Daniel Chappell & Matthias Jacob. Endothelial Glycocalyx and Coronary Vascular Permeability: the Fringe Benefit. Basic Research in Cardiology (2010) 105:687–701.

    3. F. E. Curry & R. H. Adamson. Endothelial Glycocalyx: Permeability Barrier and Mechanosensor. Annals of Biomedical Engineering (2012) 40:828–839.

    4. A. W. Mulivor & H. H. Lipowsky. Role of Glycocalyx in Leukocyte-endothelial Cell Adhesion. American Journal of Physiology: Heart and Circulatory Physiology (2002) 283(4):H1282–H1291.

    5. Sietze Reitsma, Dick W. Slaaf, Hans Vink, Marc A. M. J. van Zandvoort & Mirjam G. A. oude Egbrink. The Endothelial Glycocalyx: Composition, Functions, and Visualization. Eur J Physiol (2007) 454:345–359.

    6. Bingmei M. Fu & John M. Tarbell. Mechano-sensing and Transduction by Endothelial Surface Glycocalyx: Composition, Structure, and Function. Wiley Interdiscip Rev Syst Biol Med. (2013) 5(3): 381–390.

    7. Ties A. Mulders, Max Nieuwdorp, Erik S Stroes, Hans Vink & Sara-Joan Pinto-Sietsma. Non-invasive Assessment of Microvascular Dysfunction in Families with Premature Coronary Artery Disease. Int J Cardiol. (2013) 168(5):5026-5028.

    1. Max Nieuwdorp, Timon W. van Haeften, Mirella C.L.G. Gouverneur, Hans L. Mooij, Miriam H.P. van Lieshout, Marcel Levi, Joost C.M. Meijers, Frits Holleman, Joost B.L. Hoekstra, Hans Vink, John J.P. Kastelein & Erik S.G. Stroes. Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo. Diabetes (2006) 55(2):480-486.

    2. Claudia Nussbaum, Ana Cavalcanti Fernandes Heringa, Zuzana Mormanova, Alexandra F. Puchwein-Schwepcke, Susanne Bechtold-Dalla Pozza & Orsolya Genzel-Boroviczény. Early Microvascular Changes with Loss of the Glycocalyx in Children with Type 1 Diabetes. J Pediatr. (2014) 164(3):584-589.

    3. Carmen A. Vlahu, Bregtje A. Lemkes, Dirk G. Struijk, Marion G. Koopman, Raymond T. Krediet & Hans Vink. Damage of the Endothelial Glycocalyx in Dialysis Patients. J Am Soc Nephro (2012) l23:1900–1908.

    4. Remy J.H. Martens, Hans Vink, Robert J. van Oostenbrugge & Julie Staals. Sublingual Microvascular Glycocalyx Dimensions in Lacunar Stroke Patients. Cerebrovasc Dis (2013) 35:451–454.

    5. Elaheh Rahbar, Jessica C Cardenas, Gyulnar Baimukanova, Benjamin Usadi, Roberta Bruhn, Shibani Pati, Sisse R Ostrowski, Pär I Johansson, John B Holcomb & Charles E Wade. Endothelial Glycocalyx Shedding and Vascular Permeability in Severely Injured Trauma Patients. J Transl Med. (2015) 13:117.

    6. M. F. de Jesus Raposo, A. M. B. de Morais & R. M. S. C. De Morais. Marine Polysaccharides from Algae with Potential Biomedical Applications (2015) Mar. Drug 13:2967-3028.

     


    *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.